Magnetic resonance imaging findings in spinal tuberculosis: Comparison of HIV positive and negative patients

by Anley, Cameron Michael, Brandt, Andrew D, Dunn, Robert
Published 2012

Using simulation to evaluate wildlife survey designs: polar bears and seals in the Chukchi Sea

by Conn, Paul B., Moreland, Erin E., Regehr, Eric V., Richmond, Erin L., Cameron, Michael F., Boveng, Peter L.
Published 2016

Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains

by Benton, Cristina S., Miller, Brooke H., Skwerer, Sean, Suzuki, Oscar, Schultz, Laura E., Cameron, Michael D., Marron, J. S., Pletcher, Mathew T., Wiltshire, Tim
Published 2011

Potent suppression of HIV viral replication by a novel inhibitor of Tat

by Mousseau, Guillaume, Clementz, Mark A, Bakeman, Wendy N, Nagarsheth, Nisha, Cameron, Michael, Shi, Jun, Baran, Phil, Fromentin, Rémi, Chomont, Nicolas, Valente, Susana T
Published 2012

TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway

by Ghoshal, Sarbani, Zhu, Qingzhang, Asteian, Alice, Lin, Hua, Xu, Haifei, Ernst, Glen, Barrow, James C., Xu, Baoji, Cameron, Michael D., Kamenecka, Theodore M., Chakraborty, Anutosh
Published 2016

Cutaneous Human Papillomavirus Infection and Development of Subsequent Squamous Cell Carcinoma of the Skin

by Hampras, Shalaka S., Reed, Rhianna A., Bezalel, Spencer, Cameron, Michael, Cherpelis, Basil, Fenske, Neil, Sondak, Vernon K., Messina, Jane, Tommasino, Massimo, Gheit, Tarik, Rollison, Dana E.
Published 2016

Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists

by Solt, Laura A., Wang, Yongjun, Banerjee, Subhashis, Hughes, Travis, Kojetin, Douglas J., Lundasen, Thomas, Shin, Youseung, Liu, Jin, Cameron, Michael D., Noel, Romain, Yoo, Seung-Hee, Takahashi, Joseph S., Butler, Andrew A., Kamenecka, Theodore M., Burris, Thomas P.
Published 2012

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency

by Calvet, Claudia M., Vieira, Debora F., Choi, Jun Yong, Kellar, Danielle, Cameron, Michael D., Siqueira-Neto, Jair Lage, Gut, Jiri, Johnston, Jonathan B., Lin, Li, Khan, Susan, McKerrow, James H., Roush, William R., Podust, Larissa M.
Published 2014

Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51

by Vieira, Debora F., Choi, Jun Yong, Calvet, Claudia M., Siqueira-Neto, Jair Lage, Johnston, Jonathan B., Kellar, Danielle, Gut, Jiri, Cameron, Michael D., McKerrow, James H., Roush, William R., Podust, Larissa M.
Published 2014

Anti-Diabetic Actions of a Non-Agonist PPARγ Ligand Blocking Cdk5-Mediated Phosphorylation

by Choi, Jang Hyun, Banks, Alexander S., Kamenecka, Theodore M., Busby, Scott A., Chalmers, Michael J., Kumar, Naresh, Kuruvilla, Dana S., Shin, Youseung, He, Yuanjun, Bruning, John B., Marciano, David P., Cameron, Michael D., Laznik, Dina, Jurczak, Michael J., Schürer, Stephan C., Vidović, Dušica, Shulman, Gerald I., Spiegelman, Bruce M., Griffin, Patrick R.
Published 2011